Cicero Diagnostics is the parent company of MyReceptivaTM
Cicero Diagnostics was founded to expedite new testing technologies in the women’s healthcare sector by shortening the time from the clinical research stage to actual clinical utility.
Cicero Diagnostics is a women’s health care company founded in October 2014. It is dedicated to the advancement of clinical assays for understudied women’s diseases. MyReceptiva™ leverages the published data of our primary marker BCL6 and its ability to detect endometriosis and brings in the community of women who are looking for a less invasive and cost effective option to surgery.
In 2024, the company expanded its current test offering to bring affordable detection testing services to Ob-Gyn and other women’s healthcare professionals to increase access for all women. Cicero Diagnostics has the exclusive license to multiple markers associated with endometriosis detection in addition to their role in unexplained infertility.
The company is headquartered in Henderson, Nevada. You can learn more about the company at cicerodx.com.
Meet Our Experts
Doctor Mona Orady
FACOG Gynecologic Surgeon
Talk to your Healthcare Provider
Click the button below for information on how to speak with your doctor about MyReceptiva testing.
Dr. Orady joins the MyReceptiva team with over 20 years of experience in advanced minimally invasive and robotic surgery with over 10,000 procedures performed. Her expertise spans all forms of pelvic surgery with a large part addressing endometriosis. The role of what to do after detection of BCL6 includes the option of surgery for confirmation and treatment of endometriosis.
Dr, Orady will support our team in ensuring all MyReceptiva users have the knowledge and questions to ask if surgery is the right option for you.
Dr. Aimee Eyvazzadeh, MD
OB/GYN, Fertility Specialist
Dr. Aimee Eyvazzadeh, lovingly known as The Egg Whisperer, is a renowned fertility specialist based in the San Francisco Bay Area. She has sparked a global fertility movement with her practice, podcast, and educational platform, The Egg Whisperer Show, which has over 3 million downloads. Known for her warmth and humor, Dr. Aimee demystifies complex fertility topics and consistently tops patient review sites for her personalized approach, especially among women over 35. With a distinguished medical background from UCLA, Harvard, and the University of Michigan, Dr. Aimee continues her family’s legacy in women’s health, sharing a message of fertility, hope and positivity worldwide.
Talk to your Healthcare Provider
Click the button below for information on how to speak with your doctor about MyReceptiva testing.
Leadership Team
Christopher Jackson
CEO & President
Mr. Jackson has over 36 years of experience in healthcare sales & marketing, including 30 years of involvement with healthcare start-ups. Mr. Jackson has launched over 35 products during his career, with the majority in the field of women’s health & reproductive medicine.
With experience in product management, healthcare marketing and building and managing successful sales teams, Mr. Jackson is excited about the launch of the MyReceptiva Test and the powerful information it provides women to detect endometriosis and to help women experiencing previously unexplained infertility.
Dan Angress
COO
Mr. Angress has over 35 years experience in diagnostic medicine and women’s health care. He has overseen multiple labs in various executive capacities including business development, marketing, customer service, product management, and operations. His breadth of knowledge in women’s health and reproductive medicine covers a wide range of areas. Mr. Angress serves as the COO and scientific liaison for the company including principal investigator on Cicero’s SBIR NIH grants. He has published on the use, value, and success of BCL6 in different independent studies.
Bruce Lessey, M.D., Ph.D.
Scientific Advisor
Dr. Lessey is the Scientific Advisor for Cicero Diagnostics, Inc. and is an internationally recognized leader in uterine receptivity research and the identification of markers associated with unexplained infertility. Dr. Lessey’s extensive research background includes published research on Beta 3 Integrin and BCL6, the two key components of the current ReceptivaDx™ Assay. He has served on multiple editorial boards for major journals and published over 150 peer-reviewed articles, with a focus on infertility, endometriosis and the role of the endometrium in embryo implantation.
In addition to his research efforts, Dr. Lessey is a practicing Ob-Gyn at The Fertility Center of the Carolinas in Greenville, SC. Dr. Lessey has been helping women overcome the challenges of infertility for over 3 decades, bringing the key findings of his research into the clinical setting and helping women conceive that had given up hope of ever becoming pregnant.
Board Certification:
American Board of Obstetrics and Gynecology with added qualifications in Reproductive Endocrinology and Infertility
Fellowship:
Reproductive Endocrinology and Infertility, Hospital of the University of Pennsylvania
Memberships:
American College of Obstetricians and Gynecologists, American Society of Reproductive Medicine, American Association for the Advancement of Science
Interests:
Endometriosis, integrins and uterine receptivity, and polycystic ovary disease
Dr. Allen Gown
Pathologist
Dr. Gown has recently retired from a distinguished 40-year pathology career as a pathologist-scientist recognized as one of the world’s leading experts in the diagnostic and research applications of immunohistochemistry. He received his M.D. from the Albert Einstein College of Medicine of Yeshiva University, Bronx, NY in 1975, and then completed his Pathology Residency as well as Pathology Fellowship training at the University of Washington, Seattle, the latter under the aegis of Dr. Earl Benditt.
Dr. Gown rose through the ranks to full Professor of Pathology, building an NIH-funded research laboratory, while also serving as an attending pathologist at the University of Washington Medical Center. In the latter context, he developed a diagnostic immunohistochemistry laboratory that also served as a resource for area pathologists. In 1997, he left the University of Washington to found PhenoPath Laboratories, which over 20 years grew to become an internationally renowned diagnostic reference laboratory. Over his career, he has developed numerous clinically important monoclonal antibodies (e.g., HMB-45, 34βE12), and has contributed extensively to the expanding horizons of immunohistochemistry with over 300 peer-reviewed publications. He is currently a member of the editorial boards of several major pathology journals and is involved in several teaching endeavors, including a role as Clinical Professor of Pathology at the University of British Columbia, Vancouver, BC.
Dr. Gown has been married to his wife Carol for over 50 years, having raised 2 sons and now with 3 grandsons. He is also an ardent bicyclist and a student of classical guitar.
Dr. Gregory S. Henderson, M.D., Ph.D.
Scientific Advisor
Dr. Henderson is the Executive Vice Chairman of Anatomic Pathology and Digital Pathology at the Mount Sinai Health System in New York. He has been a practicing pathologist, specializing in breast and gynecologic pathology for over 25 years. Over the course of his career he has founded several regional pathology practices and has served in the executive roles of President of BioReference Laboratories (Elmwood Park, NJ) and System Director of Anatomic Pathology at the Ochsner Health Network (New Orleans, LA). He has been an internationally recognized innovator in the field of Digital Pathology, having led the first successful effort to organize a group of US pathologists to provide volunteer diagnostic services to thousands of patients in Haiti using a cloud-based digital pathology platform.
His undergraduate degree is from Tulane University. He earned his MD and PhD degrees at Vanderbilt University as an NIH Medical Scientist Training Program Fellow. His residency training was at Johns Hopkins Hospital and University of Utah/ARUP Laboratories, and his fellowship training was at Vanderbilt University Medical Center.
Meet Us
November 2024 – AAGL (American Association of Gynecologic Laparoscopists) – New Orleans, LA
May 16-18, 2025 – American College of Obstetrics & Gynecology ACOG ’25 – Minneapolis, MN
Investor and Media Relations
Media Relations
Contact Bela Angress
Director of Marketing and social media
Email: bela@cicerodx.com
Take charge of your health.
1 in 10 American women will be afflicted with Endometriosis, which is why we’re determined to help provide answers and solutions. Millions of women have suffered from endometriosis and have been able to find solutions.
We are here to help.
